Perceived challenges of COVID-19 infection prevention and control preparedness: A multinational survey

Ermira Tartari; Joost Hopman; Benedetta Allegranzi; Bin Gao; Andreas Widmer; Vincent Chi-Chung Cheng; Shuk Ching Wong; Kalisvar Marimuthu; Folasade Ogunsola; Andreas Voss; International Society of Antimicrobial Chemotherapy Infection and Prevention Control ISAC-IPC Working Group

doi:10.1016/j.jgar.2020.07.002

Perceived challenges of COVID-19 infection prevention and control preparedness: A multinational survey

J Glob Antimicrob Resist. 2020 Sep:22:779-781. doi: 10.1016/j.jgar.2020.07.002. Epub 2020 Jul 11.

Affiliations

¹ Infection Control Program and WHO Collaborating Centre on Patient Safety, Geneva University Hospitals and University of Geneva Faculty of Medicine, Geneva, Switzerland; Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Faculty of Health Sciences, University of Malta, Msida, Malta. Electronic address: [email protected].
² Radboudumc Center for Infectious Diseases, Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
³ Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Infection Prevention and Control Technical and Clinical Hub, Department of Integrated Health Services, World Health Organization, Geneva, Switzerland.
⁴ Infectious Disease Unit, Tianjin 4th Centre Hospital, Tianjin, China; Graduate School, Tianjin Medical University, Tianjin, China.
⁵ Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
⁶ Department of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China; Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hospital Authority, Hong Kong, China.
⁷ Infection Control Team, Queen Mary Hospital, Hong Kong West Cluster, Hospital Authority, Hong Kong, China.
⁸ Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore; National Centre for Infectious Diseases, Singapore, Singapore, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
⁹ Department of Medical Microbiology and Parasitology, College of Medicine of the University of Lagos, Lagos, Nigeria; Infection Control Africa Network, Cape Town, South Africa.
¹⁰ Radboudumc Center for Infectious Diseases, Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital (CWZ), Nijmegen, The Netherlands; REshape Center for Innovation, Radboudumc, Nijmegen, The Netherlands. Electronic address: [email protected].

No abstract available

MeSH terms

Betacoronavirus / isolation & purification
COVID-19
Coronavirus Infections / prevention & control*
Coronavirus Infections / transmission
Coronavirus Infections / virology
Cross-Sectional Studies
Disease Outbreaks
Health Facilities
Health Knowledge, Attitudes, Practice*
Humans
Infection Control / methods
Infection Control / standards*
Infectious Disease Transmission, Patient-to-Professional / prevention & control
Internationality
Pandemics / prevention & control*
Personal Protective Equipment / supply & distribution
Pneumonia, Viral / prevention & control*
Pneumonia, Viral / transmission
Pneumonia, Viral / virology
SARS-CoV-2
Surveys and Questionnaires

Grants and funding

001/WHO_/World Health Organization/International